N/A A Phase III Trial of Risk-Stratified, Reduced Intensity Adjuvant Treatment in Patients Undergoing Transoral Surgery for Human Papillomavarius (HPV)-Positive Oropharyngeal Cancer

NCT02215265

A Phase III Trial of Risk-Stratified, Reduced Intensity Adjuvant Treatment in Patients Undergoing Transoral Surgery for Human Papillomavarius (HPV)-Positive Oropharyngeal Cancer

Associated Conditions

Head and Neck Cancer

Principal Investigator

Bruce Haughey

Sponsor

PATHOS Velindre Uni NHS Trust and Cardiff Uni

This study aims to identify the best way of treating orpharyngeal cancer that are caused by HPV. At the moment, cancers caused by HPV are treated like any other cancer in the Head and Neck and the survival rate is very good. The study is looking to see if the treatment can be modified to reduce the risk of side-effects caused by the treatment.

This study is currently enrolling.